Ludwig Hantson has sold ALXN and made no open-market buys since Jan 2018
CEO at Alexion Pharmaceuticals, Inc.
SEC CIK 0001491435 · Filings on SEC.gov ↗
$0Bought
$2.2MSold
NoneLast buy
Every filing
3 filings since Jan 2018, newest first
Filings come from SEC EDGAR. Not investment advice.